Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nurse training may cut ICU infections in bangladesh

NCT ID NCT07299799

Knowledge-focused Sponsor: Hiroshima University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether training intensive care nurses in evidence-based practices can lower rates of ventilator-associated pneumonia, pressure ulcers, and central line bloodstream infections. Researchers will train nurses and use advanced equipment, then compare infection rates before and after the training. About 272 patients and their nurses in Bangladesh will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nurse training and advanced equipment
What this could lead to
If successful, this could show that training nurses in evidence-based practices reduces common ICU infections and injuries, improving patient safety.
What could go wrong
This is a small, early-stage study in one country, so results may not apply elsewhere. It also does not test a new drug or device, so the impact is limited to hospital procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 272 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Trial 1 \& 2- Inclusion Criteria: Nurse * who is a registered nurse in Bangladesh. * who agrees to participate in this study and the EBP training. * who will stay at the ICU for 6 months. Patient * Irrespective of age and sex, participants must be at least 18 years old * Legal guardian of a patient consent to participation in the study Exclusion Criteria: Nurse * Who will not directly involve patient care in ICU. Patient * No exclusion criteria

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central line associated blood stream infections (clabsi) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

decubitus ulcer Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central line associated blood stream infections (clabsi) Medical device related pressure ulcer (mdrpu) Pressure ulcer (PU) Ventilator acquired pneumonia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dhaka Medical College Hospital

    Dhaka, Dhaka Division, Bangladesh

  • Hiroshima University

    Hiroshima, Hiroshima City, 7348551, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.